Enrollment completed in Phase III Copaxone MS trial

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Enrollment completed in Phase III Copaxone MS trial

Postby MSUK » Thu Jun 02, 2011 7:15 am

Image


Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase III trial in patients with relapsing-remitting multiple sclerosis (RRMS), is designed to examine the efficacy, safe... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2223
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Postby cathyb » Sat Jun 11, 2011 6:30 pm

Ugh, Mark Freedman.
User avatar
cathyb
Family Member
 
Posts: 63
Joined: Tue Dec 29, 2009 3:00 pm


Return to Copaxone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service